Saturday, July 20, 2024
HomeNewsHealth Think Tank has developed a medicine that keeps weight down surprisingly

Health Think Tank has developed a medicine that keeps weight down surprisingly


Related stories

The Human and Economic Toll of Climate Neglect in Pakistan

Climate change is a pressing global issue, with far-reaching...

Why German Companies Fear Chinese Competition?

In recent years, the rapid growth of Chinese influence...

Is Israel Justifying Genocide Amid War Tactics?

The question of whether Israel is attempting to justify...

Trump Attack Allegations: How Possible is Iran’s Involvement?

Recent reports alleging Iran's involvement in plotting to assassinate...

Saudi Arabia Scores Big: Hosting Olympic Esports Games 2025

In a groundbreaking move, the International Olympic Committee (IOC)...

A joint think tank from three research institutions has achieved a significant single milestone in developing a weight-loss maintenance medicine.

Many health problems can be solved by reducing the weight of the human body. American scientists have found a unique solution to this problem, with the help of which weight loss can be brought about with the help of normal diet.

Interestingly researchers at UT Health San Antonio, along with collaborators from the University of Pennsylvania and Cornell University, successfully, have prepared a small-molecule drug called CPACC that limits magnesium transport in cellular power plants called mitochondria.

Durring research, this medicine has been shown to prevent weight gain and adverse liver changes in mice on a high-sugar, high-fat diet. It is fact that by reducing magnesium transport in the mitochondria, the drug enhances metabolism of sugar and fat, resulting in slimmer and healthier mice with no evidence of fatty liver disease.

The researchers have filed a patent application for the drug, which has potential implications in reducing the risk of cardiometabolic diseases and liver cancer.

With the help of this drug, the severity of many other related diseases can also be reduced but a little caution is required.

A health think tank is preparing to launch a clinical trial of a drug derived from this research.

Zain Saleem
Zain Saleem
Zain Saleem is an Islamabad-based Senior Journalist

Latest stories




Please enter your comment!
Please enter your name here